Safety and Efficacy of MEK Inhibitor Treatment for Gastric Precancerous Lesions
- DOI
- 10.1053/j.gastro.2025.05.023
- Published
- 2025-09
- Container
- Gastroenterology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1053/j.gastro.2025.05.023,
title = {Safety and Efficacy of MEK Inhibitor Treatment for Gastric Precancerous Lesions},
author = {James R. Goldenring and Bogun Jang and Takuji Gotoda and Naoyuki Yamaguchi and Eunyoung Choi and Sachiyo Nomura and Kimberly S. Presentation and Su-Hyung Lee and Ayaka Takasu and Taro Akashi and Koichi Yagi and Rei Sakata},
year = {2025},
journal = {Gastroenterology},
doi = {10.1053/j.gastro.2025.05.023},
url = {https://doi.org/10.1053/j.gastro.2025.05.023}
}RIS
TY - JOUR TI - Safety and Efficacy of MEK Inhibitor Treatment for Gastric Precancerous Lesions AU - James R. Goldenring AU - Bogun Jang AU - Takuji Gotoda AU - Naoyuki Yamaguchi AU - Eunyoung Choi AU - Sachiyo Nomura AU - Kimberly S. Presentation AU - Su-Hyung Lee AU - Ayaka Takasu AU - Taro Akashi AU - Koichi Yagi AU - Rei Sakata PY - 2025 JO - Gastroenterology DO - 10.1053/j.gastro.2025.05.023 UR - https://doi.org/10.1053/j.gastro.2025.05.023 ER -
APA
Goldenring, J. R., Jang, B., Gotoda, T., Yamaguchi, N., Choi, E., Nomura, S., Presentation, K. S., Lee, S., Takasu, A., Akashi, T., Yagi, K., & Sakata, R. (2025). Safety and Efficacy of MEK Inhibitor Treatment for Gastric Precancerous Lesions. Gastroenterology. https://doi.org/10.1053/j.gastro.2025.05.023
Source records
- crossref · retrieved 2026-09-27T03:17:10.650Z